Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.
Hypogonadism, Spinal Cord Injury
About this trial
This is an interventional diagnostic trial for Hypogonadism focused on measuring Hypogonadal, Hypothalamus, Pituitary, Spinal Cord Injury, Testes, Testosterone
Eligibility Criteria
Inclusion Criteria: SCI with serum total testosterone 3.0 ng/ml (SCI eugonadal, n=25), SCI with serum total testosterone <3.0 ng/ml (SCI hypogonadal, n=25), able-bodied controls with serum total testosterone 3.0 ng/ml (control eugonadal, n=25), and able-bodied controls with serum total testosterone <3.0 ng/ml (control hypogonadal, n=25). All SCI and control subjects will be screened for serum gonadotropin levels within the normal range as an inclusion criterion. Exclusion Criteria: acute illness, active thyroid disease, pyschotropic medications, anti-hypertensive medications (centrally acting, i.e., guanethidine, reserpine, methyldopa, b-adrenergic blockers, clonidine, etc.), H2-blockers, digoxin, alcoholism, anti-convulsant medications (dilantin or barbiturates) diuretics (thiazides or spironolactone), chemotherapeutic agents, antibiotics, opiates, hormones (other than replacement doses), history of pituitary or testicular surgery. Abstinence from alcoholic beverages will be required for 48 hours prior to study.
Sites / Locations
- VA Medical Center, Bronx
Arms of the Study
Arm 1
Other
1